tranexamic acid has been researched along with Cardiomyopathies in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosgör, I | 1 |
| Yarat, A | 1 |
| Yilmazer, S | 1 |
| Girisken, G | 1 |
| Ahmad, S | 1 |
1 other study available for tranexamic acid and Cardiomyopathies
| Article | Year |
|---|---|
Collagen deposition in myocardium after inhibition of fibrinolytic activity.
Topics: Animals; Antifibrinolytic Agents; Cardiomyopathies; Cats; Collagen; Female; Fibrinolysis; Male; Myoc | 2005 |